Cracking the Code: Optimizing Outcomes in All Patients With High-Risk HR+/HER2-Negative Early Breast Cancer

episode

Keeping Current CME not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

NPR News: 09-27-2026 6AM EDT 5 min · 27 Sep 2026 · NPR News Now

THE KNIGHTS ARE INTO THE GRAND FINAL! Was It The Best Performance Ever? | The Verdict 50 min · 27 Sep 2026 · Triple M Rocks Footy NRL

Building a Team at AI Speed | Harvey’s Maggie Landers 48 min · 27 Sep 2026 · The a16z Show

The Best TV Shows of the 21st Century 59 min · 27 Sep 2026 · The Daily

Will a Rent Freeze Fix NYC or Make it Worse? 20 min · 27 Sep 2026 · The Journal.

Making Sense of Sky-High Treasury Yields 37 min · 27 Sep 2026 · WSJ's Take On the Week

Report any issue

Source

Recorded27 Apr 2026

Publisherkeepingcurrentcme.libsyn.com ↗

Handlerec:18143137

Show notes

Master assessing high-risk hormone receptor (HR)-positive/HER2-negative early breast cancer (EBC): outsmart recurrence with data-driven precision. Credit available for this activity expires: 04/27/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/cracking-code-optimizing-outcomes-all-patients-high-risk-hr-2026a1000crj?ecd=bdc_podcast_libsyn_mscpedu

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in